Zhejiang Hisun Pharmaceutical's (SHA:600267) shareholder, Zhejiang International Trade Group, completed transferring 6.16% of the company to a new investor, according to a Thursday disclosure with the Shanghai bourse.
Jinpu Zhezhan Equity Investment (Lishui) Partnership (Limited Partnership) acquired the stake, or 72.7 million shares of the pharmaceutical company, for 751.4 million yuan.
After the transaction, Zhejiang International Trade no longer owns any stake in the company.
The company's shares rose 2% during the afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments